Cartesian Therapeutics, Inc.
RNAC
$8.84
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 140.25% | 57.68% | -157.86% | -326.00% | 189.70% |
| Total Depreciation and Amortization | 26.67% | 1.15% | 0.33% | 2.89% | -49.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -355.85% | -77.96% | 287.45% | 158.99% | -6,253.03% |
| Change in Net Operating Assets | 6,130.88% | 2,366.67% | -100.57% | 135.15% | 78.71% |
| Cash from Operations | 4.76% | -24.97% | -13.54% | 10.96% | 24.18% |
| Capital Expenditure | -907.41% | 94.51% | 61.92% | 50.21% | -141.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -907.41% | 94.51% | 61.92% | 50.21% | -141.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -72.47% | 31,242.00% | 900.00% | -94.12% | -53.55% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -137.21% | -72.00% | 99.70% |
| Cash from Financing | 221.26% | 30,236.54% | -36.84% | -163.33% | 100.75% |
| Foreign Exchange rate Adjustments | -257.14% | -163.64% | 210.00% | -183.33% | -62.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 545.75% | 64.38% | -7.70% | 15.49% | 37.71% |